Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Meloxicam Rapid Release Tablet PK
NCT02183103Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 1999
- Primary completion
- May 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of meloxicam in osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration of the analyte in plasma at 96 hours and Area under the concentration-time curve of the analyte in plasma from time zero to infinity at 96 hours. Started Apr 1999; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02183103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183103.